Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 51 results.
User Information
Export Records
  1. 1.   Lessons in self-defence: inhibition of virus entry by intrinsic immunity
  2. Majdoul,Saliha; Compton,Alex
  3. Nature Reviews Immunology. 2021, Oct 13;
  1. 2.   Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors
  2. Wu, Yumeng; Tang, Chengrun; Rui, Ruomei; Yang, Liumeng; Ding, Wei; Wang, Jiangyuan; Li, Yiming; Lai,Christopher; Wang, Yueping; Luo, Ronghua; Xiao, Weilie; Zhang, Hongbing; Zheng, Yongtang; He, Yanping
  3. Acta pharmaceutica Sinica. B. 2020, Mar; 10(3): 512-528.
  1. 3.   Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
  2. He, Y. P.; Long, J.; Zhang, S. S.; Li, C.; Lai, C. C.; Zhang, C. S.; Li, D. X.; Zhang, D. H.; Wang, H.; Cai, Q. Q.; Zheng, Y. T.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jan; 21(2): 694-697.
  1. 4.   Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif
  2. Smith, J. L.; Pathak, V. K.
  3. Journal of Virology. 2010, Dec; 84(24): 12599-12608.
  1. 5.   Synthesis of Conformationally Locked L-Deoxythreosyl Phosphonate Nucleosides Built on a Bicyclo[3.1.0]hexane Template
  2. Saneyoshi, H.; Deschamps, J. R.; Marquez, V. E.
  3. Journal of Organic Chemistry. 2010, Nov 19; 75(22): 7659-7669.
  1. 6.   Selective Modulation of DNA Polymerase Activity by Fixed-Conformation Nucleoside Analogues
  2. Eoff, R. L.; McGrath, C. E.; Maddukuri, L.; Salamanca-Pinzon, S. G.; Marquez, V. E.; Marnett, L. J.; Guengerich, F. P.; Egli, M.
  3. Angewandte Chemie-International Edition. 2010, Oct 4; 49(41): 7481-7485.
  1. 7.   APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
  2. Mbisa, J. L.; Bu, W.; Pathak, V. K.
  3. Journal of Virology. 2010, May; 84(10): 5250-5259.
  1. 8.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 9.   Highly Efficient Method for C-5 Halogenation of Pyrimidine-Based Nucleosides in Ionic Liquids
  2. Kumar, V.; Yap, J.; Muroyama, A.; Malhotra, S. V.
  3. Synthesis-Stuttgart. 2009, Dec; (23): 3957-3962.
  1. 10.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
  1. 11.   Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
  2. Friew, Y. N.; Boyko, V.; Hu, W. S.; Pathak, V. K.
  3. Retrovirology. 2009 6 AR 56
  1. 12.   Multivalent Interactions with gp120 Are Required for the Anti-HIV Activity of Cyanovirin
  2. Liu, Y. A.; Carroll, J. R.; Holt, L. A.; McMahon, J.; Giomarelli, B.; Ghirl, a
  3. Biopolymers. 2009 92(3): 194-200.
  1. 13.   Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet
  2. Perkovic, M.; Schmidt, S.; Marino, D.; Russell, R. A.; Stauch, B.; Hofmann, H.; Kopietz, F.; Kloke, B. P.; Zielonka, J.; Strover, H.; Hermle, J.; Lindemann, D.; Pathak, V. K.; Schneider, G.; Lochelt, M.; Cichutek, K.; Munk, C.
  3. Journal of Biological Chemistry. 2009 284(9): 5819-5826.
  1. 14.   Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference
  2. Rausch, J. W.; Chelico, L.; Goodman, M. F.; Le Grice, S.
  3. Journal of Biological Chemistry. 2009 284(11): 7047-7058.
  1. 15.   Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
  2. Russell, R. A.; Smith, J.; Barr, R.; Bhattacharyya, D.; Pathak, V. K.
  3. Journal of Virology. 2009 83(4): 1992-2003.
  1. 16.   IFN alpha and IFN lambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity
  2. Maher, S. G.; Sheikh, F.; Scarzello, A. J.; Romero-Weaver, A. L.; Baker, D. P.; Donnelly, R. P.; Gamero, A. M.
  3. Cancer Biology & Therapy. 2008 7(7): 1109-1115.
  1. 17.   The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA(3)(Lys) annealing to viral RNA
  2. Guo, F.; Cen, S.; Niu, M. J.; Yang, Y. L.; Gorelick, R. J.; Kleiman, L.
  3. Journal of Virology. 2007, Oct; 81(20): 11322-11331.
  1. 18.   Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
  2. Russell, R. A.; Pathak, V. K.
  3. Journal of Virology. 2007, Aug; 81(15): 8201-8210.
  1. 19.   Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
  2. Mbisa, J. L.; Barr, R.; Thomas, J. A.; Vandegraaff, N.; Dorweiler, I. J.; Svarovskaia, E. S.; Brown, W. L.; Mansky, L. M.; Gorelick, R. J.; Harris, R. S.; Engelman, A.; Pathak, V. K.
  3. Journal of Virology. 2007, Jul; 81(13): 7099-7110.
  1. 20.   Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine
  2. Ziolkowska, N. E.; Shenoy, S. R.; O'Keefe, B. R.; Wlodawer, A.
  3. Protein Science. 2007, Jul; 16(7): 1485-1489.
  1. 21.   Gag-specific CD8(+) T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression
  2. Sacha, J. B.; Chung, C.; Rakasz, E. G.; Spencer, S. P.; Jonas, A. K.; Bean, A. T.; Lee, W.; Burwitz, B. J.; Stephany, J. J.; Loffredo, J. T.; Allison, D. B.; Adnan, S.; Hoji, A.; Wilson, N. A.; Friedrich, T. C.; Lifson, J. D.; Yang, O. O.; Watkins, D. I.
  3. Journal of Immunology. 2007, Mar; 178(5): 2746-2754.
  1. 22.   Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
  2. Derse, D.; Hill, S. A.; Princler, G.; Lloyd, P.; Heidecker, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Feb; 104(8): 2915-2920.
  1. 23.   Polymorphisms of CUL5 are associated with CD4(+) T cell loss in HIV-1 infected individuals
  2. An, P.; Duggal, P.; Wang, L. H.; O'Brien, S. J.; Donfield, S.; Goedert, J. J.; Phair, J.; Buchbinder, S.; Kirk, G. D.; Winkler, C. A.
  3. Plos Genetics. 2007, Jan; 3(1):
  1. 24.   Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
  2. Deng, J. X.; Kelley, J. A.; Barchi, J. J.; Sanchez, T.; Dayam, R.; Pommier, Y.; Neamati, N.
  3. Bioorganic & Medicinal Chemistry. 2006, JUN 1; 14(11): 3785-3792.
  1. 25.   Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture
  2. Giomarelli, B.; Schumacher, K. M.; Taylor, T. E.; Sowder, R. C.; Hartley, J. L.; McMahon, J. B.; Mori, T.
  3. Protein Expression and Purification. 2006, MAY; 47(1): 194-202.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel